Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07502599 · ClinicalTrials.gov registry record
Fainting Detection And Early Warning In Syncope Evaluation Study (ARISE)
A clinical trial, sponsored by Boston Scientific Corporation.
- Recruiting
- Registry status
- 40
- Enrollment target
NCT07502599 is a clinical trial that is actively recruiting participants, run by Boston Scientific Corporation. The registered enrollment target is 40 participants.
The verdict
NCT07502599 is actively recruiting participants, sponsored by Boston Scientific Corporation.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
Study Summary
To characterize the impact of orthostatic hypotension (OH) and Vasovagal syncope on signals measured using a wearable Holter monitor in the clinic and ambulatory setting. To evaluate the relationship of signals measured from the Holter monitor with reported symptom severity of orthostatic intolerance per standard data collection, analysis, and questionnaires.
Interventions
- DEVICE Wearable holter monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07502599
The ClinicalTrials.gov registry entry for NCT07502599 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Wearable holter monitor is the first listed.
NCT07502599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07502599 about?
NCT07502599 is a clinical study titled "Fainting Detection And Early Warning In Syncope Evaluation Study (ARISE)". To characterize the impact of orthostatic hypotension (OH) and Vasovagal syncope on signals measured using a wearable Holter monitor in the clinic and ambulatory setting. To evaluate the relationship of signals measured from the Holter monitor with reported symptom severity of orthostatic intoleran...
What is the current status of trial NCT07502599?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2026-06. Estimated completion is 2028-08.
What interventions are being tested in trial NCT07502599?
The interventions under investigation include: Wearable holter monitor (DEVICE).
Who is sponsoring clinical trial NCT07502599?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.